Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,807 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists.
Saposnik G, Andhavarapu S, Fernández Ó, Kim HJ, Wiendl H, Foss M, Zuo F, Havrdová EK, Celius EG, Caceres F, Magyari M, Bermel R, Costa A, Terzaghi M, Kalincik T, Popescu V, Amato MP, Montalban X, Oh J. Saposnik G, et al. Among authors: kim hj. Mult Scler Relat Disord. 2022 Jan;57:103389. doi: 10.1016/j.msard.2021.103389. Epub 2021 Nov 13. Mult Scler Relat Disord. 2022. PMID: 35158479
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Carroll WM, Saida T, Kim HJ, Kira J, Kermode AG, Tsai CP, Fujihara K, Kusunoki S, Tanaka M, Kim KK, Bates D; Pam-Asian Committee on Treatment and Research of Multiple Sclerosis. Carroll WM, et al. Among authors: kim kk, kim hj. Mult Scler. 2013 Sep;19(10):1371-80. doi: 10.1177/1352458512471092. Epub 2013 Jan 16. Mult Scler. 2013. PMID: 23325588
Changing patterns of multiple sclerosis in Korea: Toward a more baseline MRI lesions and intrathecal humoral immune responses.
Shin HJ, Hyun JW, Kim SH, Park MS, Sohn EH, Baek SH, Kim BJ, Choi K, Oh J, Cho JY, Kwon O, Kim W, Kim JE, Min JH, Kim BJ, Oh SY, Bae JS, Park KH, Oh JH, Sohn SY, Jang MJ, Sung JJ, Kim HJ, Kim SM. Shin HJ, et al. Among authors: kim w, kim hj, kim sh, kim bj, kim sm, kim je. Mult Scler Relat Disord. 2019 Oct;35:209-214. doi: 10.1016/j.msard.2019.08.004. Epub 2019 Aug 5. Mult Scler Relat Disord. 2019. PMID: 31401425
Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab.
Wiendl H, Carraro M, Comi G, Izquierdo G, Kim HJ, Sharrack B, Tornatore C, Daizadeh N, Chung L, Jacobs AK, Hogan RJ, Wychowski LV, Van Wijmeersch B; CARE-MS I, CARE-MS II, and CAMMS03409 Investigators. Wiendl H, et al. Among authors: kim hj. Neurol Neuroimmunol Neuroinflamm. 2019 Oct 29;7(1):e635. doi: 10.1212/NXI.0000000000000635. Print 2020 Jan. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31662412 Free PMC article. Clinical Trial.
Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies.
Comi G, Alroughani R, Boster AL, Bass AD, Berkovich R, Fernández Ó, Kim HJ, Limmroth V, Lycke J, Macdonell RA, Sharrack B, Singer BA, Vermersch P, Wiendl H, Ziemssen T, Jacobs A, Daizadeh N, Rodriguez CE, Traboulsee A; CARE-MS I, CARE-MS II, CAMMS03409, and TOPAZ Investigators. Comi G, et al. Among authors: kim hj. Mult Scler. 2020 Dec;26(14):1866-1876. doi: 10.1177/1352458519888610. Epub 2019 Nov 25. Mult Scler. 2020. PMID: 31762387 Free PMC article.
MSJ 2020 - Editorial comment.
Thompson AJ, Cohen JA, Kim HJ, Geurts J. Thompson AJ, et al. Among authors: kim hj. Mult Scler. 2020 Feb;26(2):134. doi: 10.1177/1352458519899322. Mult Scler. 2020. PMID: 32052712 No abstract available.
21,807 results
You have reached the last available page of results. Please see the User Guide for more information.